Android app Apple app link

GSK plc (GSK)'s Asthma Drug Gets FDA Nod to Treat 'Smoker's Lung'

By Yahoo! Finance   |   1 month ago
GSK plc (GSK)'s Asthma Drug Gets FDA Nod to Treat 'Smoker's Lung'

The FDA approved GSK's asthma drug, Nucala, for treating a type of COPD, expanding its use as an add-on therapy. The medication targets interleukin-5 to reduce lung inflammation. GSK highlighted the increasing burden of COPD-related hospitalizations on the healthcare system.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.